Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Influenza HA1-flagellin fusion vaccines well tolerated in healthy volunteers

Oct. 27, 2011

BF-200 ALA shows efficacy in treating actinic keratosis in advanced studies

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

New data presented from CARE-MS trials of alemtuzumab

Oct. 26, 2011

Qutenza shows efficacy in HIV-associated neuropathy

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

Phase III briakinumab data analyzed

Oct. 26, 2011

Phase III trial shows safety/tolerability of BG-12 in MS

Oct. 25, 2011

AMG-827 improves quality of life in patients with plaque psoriasis

Oct. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...